Document:

Exhibit 4.1

 

AVALON GLOBOCARE CORP.

STOCK OPTION AGREEMENT

 

 

 

This
Stock Option Agreement ("Agreement") is made and entered into as of the date set forth below, by and
between AVALON GLOBOCARE CORP., a Delaware corporation (the "Company"), and the following employee of the Company
(herein, the "Optionee"):

 

In consideration of the covenants herein
set forth, the parties hereto agree as follows:

 

1. Option Information.

	 	(a)	Date of Option:	February 21, 2017
	 	(b)	Optionee:	Luisa Ingargiola
	 	(c)	Number of Shares:	2,000,000
	 	(d)	Exercise Price:	$0.50 per share

 

2. Acknowledgements.

			(a) Optionee is an employee and executive officer of the Company and the Company and the Optionee
have entered into that certain Executive Retention Agreement on the date hereof (the “Retention Agreement”)
;

 

(b)
The Board of Directors (the “Board”) has authorized the granting to Optionee of a stock option ("Option")
to purchase shares of common stock having a par value of $0.0001 per share of the Company ("Stock") upon the terms
and conditions hereinafter stated and pursuant to an exemption from registration under the Securities Act of 1933, as amended (the
"Securities Act") provided by Rule 701 and Section 4(a)(2) thereunder.

 

3. Shares; Price.
The Company hereby grants to Optionee the right to purchase, upon and subject to the terms and conditions herein stated, the number
of shares of Stock set forth in Section 1(c) above (the "Shares") for cash, or pursuant to a Cashless Exercise
(as defined below) at the price per Share set forth in Section 1(d) above (the "Exercise Price").

 

4. Term of Option.
This Option shall expire, and all rights hereunder to purchase the Shares, shall terminate ten (10) years from the date hereof.
Vesting under this Option shall earlier terminate pursuant to Sections 7 and 8 hereof upon, and as of the date of, the termination
of Optionee's employment if such termination occurs prior to the end of such ten (10) year period, subject to the terms of any
retention or other employment agreement, which may have been or may be entered into by the Company with the Optionee, which shall
prevail in the event of any conflict with the provisions of this Agreement. Nothing contained herein shall confer upon Optionee
the right to the continuation of his or her employment by or office with the Company or to interfere with the right of the Company
to terminate such employment or to increase or decrease the compensation of Optionee from the rate in existence at the date hereof.

 

5. Vesting of Option.
Subject to the provisions of Sections 7 and 8 hereof, this Option shall vest in 36 equal tranches commencing on the date hereof.

 

    	 	-1-	 

     

    

  

6. Exercise.
This Option may be exercised during the Term of this Option by delivery to the Company of (a) written notice of exercise stating
the number of Shares being purchased (in whole shares only) and such other information set forth on the form of Notice of Exercise
attached hereto as Appendix A, (b) a check or cash in the amount of the Exercise Price of the Shares covered by the notice
(or such other consideration as has been approved by the Board of Directors) and (c) a written investment representation as provided
for in Section 13 hereof. Notwithstanding anything to the contrary contained in this Option, this Option may be exercised by presentation
and surrender of this Option to the Company at its principal executive offices with a written notice of the holder’s intention
to effect a cashless exercise, including a calculation of the number of shares of Common Stock to be issued upon such exercise
in accordance with the terms hereof (a “Cashless Exercise”). In the event of a Cashless Exercise, in lieu of paying
the Exercise Price in cash, the holder shall surrender this Option for that number of shares of Common Stock determined by multiplying
the number of Shares to which it would otherwise be entitled by a fraction, the numerator of which shall be the difference between
the then current Market Price per share of the Common Stock and the Exercise Price, and the denominator of which shall be the then
current Market Price per share of Common Stock. Market Price is defined as the average closing price on the principal trading market
for the Common Stock during the thirty (30) trading days immediately preceding the exercise date. This Option shall not be assignable
or transferable, except by will or by the laws of descent and distribution.

 

7. Termination of
Employment. If Optionee shall cease to be employed by the Company as a result of a Change of Control (as defined in the Retention
Agreement) or after the one year anniversary of the date hereof as a result of an Involuntary Termination (as defined in the Retention
Agreement), the vesting of this Option shall be accelerated to provide for full vesting. If Optionee shall cease to be employed
by the Company for any reason other than Change of Control, Involuntary Termination or by his or her death, (a) vesting of the
Shares pursuant to Section 5 shall immediately cease; and (b) Optionee (or if the Optionee shall die after such termination, but
prior to such exercise date, Optionee's personal representative or the person entitled to succeed to the Option) shall have the
right at any time within three (3) months following such termination of employment or the remaining term of this Option, whichever
is the lesser, to exercise in whole or in part this Option to the extent, but only to the extent, that this Option was exercisable
as of the date of termination of employment and had not previously been exercised; provided, however: if Optionee is permanently
disabled (within the meaning of Section 22(e)(3) of the Code) at the time of termination, the foregoing three (3) month period
shall be extended to six (6) months.

 

8. Death of Optionee.
If the Optionee shall die while in the employ of the Company, (a) vesting of the Shares pursuant to Section 5 shall immediately
cease; and (b) Optionee's personal representative or the person entitled to Optionee's rights hereunder may at any time within
six (6) months after the date of Optionee's death, or during the remaining term of this Option, whichever is the lesser, exercise
this Option and purchase Shares to the extent, but only to the extent, that Optionee could have exercised this Option as of the
date of Optionee's death; provided, in any case, that this Option may be so exercised only to the extent that this Option has not
previously been exercised by Optionee.

 

9. No Rights as
Shareholder. Optionee shall have no rights as a shareholder with respect to the Shares covered by any installment of this Option
until the effective date of the issuance of shares following exercise of this to Option, and no adjustment will be made for dividends
or other rights for which the record date is prior to the date such stock certificate or certificates are issued except as provided
in Section 10 hereof.

 

10. Recapitalization.
Subject to any required action by the shareholders of the Company, the number of Shares covered by this Option, and the Exercise
Price thereof, shall be proportionately adjusted for any increase or decrease in the number of issued shares resulting from a subdivision
or consolidation of shares or the payment of a stock dividend.

 

11. Taxation upon
Exercise of Option.

 

		(a)	Optionee understands that, upon exercise of this Option, Optionee will become liable for Federal,
state, local or foreign income taxes, based on the amount by which the fair market value of the Shares, determined as of the date
of exercise, exceeds the Exercise Price.

 

    	 	-2-	 

     

    

  

		(b)	If the Company, in its discretion, determines that it is obligated to withhold any taxes in connection
with the exercise of the Option, the Optionee must make arrangements satisfactory to the Company to pay or provide for any applicable
federal, state, local or foreign withholding obligations of the Company. The Optionee may satisfy any federal, state, local or
foreign tax withholding obligation relating to the exercise of the Option by any of the means set forth in Section 6, or the Company
has the right to withhold Taxes from any compensation payable to Optionee.

 

		(c)	Notwithstanding any action the Company takes with respect to any or all taxes, the ultimate liability
for all taxes is and remains the Optionee's responsibility and the Company (a) makes no representation or undertakings regarding
the calculation or treatment of any taxes in connection with the grant, vesting, or exercise of the Option or the subsequent sale
of any Shares acquired on exercise; and (b) does not commit to structure the Option to reduce or eliminate the Optionee's liability
for any taxes.

 

12. Modification,
Extension and Renewal of Options. The Board may modify, extend or renew this Option or accept the surrender thereof (to the
extent not theretofore exercised) and authorize the granting of a new option in substitution therefore (to the extent not theretofore
exercised). Notwithstanding the foregoing provisions of this Section 12, no modification shall, without the consent of the Optionee,
alter to the Optionee's detriment or impair any rights of Optionee hereunder.

 

13. Investment Intent;
Restrictions on Transfer.

 

			(a) Optionee represents and agrees that if Optionee exercises this Option in whole or in part,
Optionee will in each case acquire the Shares upon such exercise for the purpose of investment and not with a view to, or for resale
in connection with, any distribution thereof; and that upon such exercise of this Option in whole or in part, Optionee shall furnish
to the Company a written statement to such effect, satisfactory to the Company in form and substance. If the Shares represented
by this Option are registered under the Securities Act, either before or after the exercise of this Option in whole or in part,
the Optionee shall be relieved of the foregoing investment representation and agreement and shall not be required to furnish the
Company with the foregoing written statement.

 

			(b) Optionee further represents that Optionee has had access to the financial statements or books
and records of the Company, has had the opportunity to ask questions of the Company concerning its business, operations and financial
condition, and to obtain additional information reasonably necessary to verify the accuracy of such information.

(c) Unless and until the Shares represented by this Option are registered under the Securities Act, all certificates representing
the Shares and any certificates subsequently issued in substitution therefor and any certificate for any securities issued pursuant
to any stock split, share reclassification, stock dividend or other similar capital event shall bear legends in substantially the
following form:

 

			THESE SECURITIES HAVE NOT BEEN REGISTERED OR OTHERWISE QUALIFIED UNDER THE SECURITIES ACT OF 1933
(THE 'SECURITIES ACT') OR UNDER THE APPLICABLE OR SECURITIES LAWS OF ANY STATE. NEITHER THESE SECURITIES NOR ANY INTEREST THEREIN
MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE
SECURITIES LAWS OF ANY STATE, UNLESS PURSUANT TO EXEMPTIONS THEREFROM.

 

    	 	-3-	 

     

    

  

and/or such other legend or legends
as the Company and its counsel deem necessary or appropriate. Appropriate stop transfer instructions with respect to the Shares
have been or may be placed with the Company's transfer agent.

 

14. Notices.
Any notice required to be given pursuant to this Option shall be in writing and shall be deemed to be delivered upon receipt or,
in the case of notices by the Company, five (5) days after deposit in the U.S. mail, postage prepaid, addressed to Optionee at
the address last provided by Optionee for use in Company records related to Optionee.

 

15. This Option has
been granted, executed and delivered in the State of New York, and the interpretation and enforcement shall be governed by the
laws thereof and subject to the exclusive jurisdiction of the courts therein.

 

In
Witness Whereof, the parties hereto have executed this Option as of the date first above written.

 

	 	COMPANY: 	AVALON GLOBOCARE CORP.,
	 	 	a Delaware corporation
	 	 	 
	 	 	By: /s/ David Jin
	 	 	Name: David Jin
	 	 	Title:CEO
	 	 	 
	 	OPTIONEE:	LUISA INGARGIOLA
	 	 	 
	 	 	/s/Luisa Ingargiola

 

    	 	-4-	 

     

    

  

Appendix A

 

NOTICE OF EXERCISE

 

AVALON GLOBOCARE CORP.

_________________

_________________

_________________

 

Re: Stock Option

 

1)       Notice
is hereby given pursuant to Section 6 of my Stock Option Agreement that I elect to purchase the number of shares set forth below
at the exercise price set forth in my option agreement:

 

Stock Option Agreement
dated: ______________

 

Number of shares being
purchased: ____________

 

Exercise Price: $____________

 

A check in the amount
of the aggregate price of the shares being purchased is attached.

 

OR

 

2)       I
elect a cashless exercise pursuant to Section 6 of my Stock Option Agreement. The Market Price as of _______ was $_______.

 

I hereby confirm that
such shares are being acquired by me for my own account for investment purposes, and not with a view to, or for resale in connection
with, any distribution thereof. I will not sell or dispose of my Shares in violation of the Securities Act of 1933, as amended,
or any applicable federal or state securities laws.

 

I understand that the
certificate representing the Option Shares will bear a restrictive legend within the contemplation of the Securities Act and as
required by such other state or federal law or regulation applicable to the issuance or delivery of the Option Shares.

 

	 	By:	 
	 	 	(signature)
	 	Name:

 

    	 	-5-Exhibit 10.1

 

EXECUTIVE RETENTION AGREEMENT

 

This Executive Retention
Agreement (the “Agreement”) is made and entered into as of February 21, 2017 effective February 9, 2017
(the “Effective Date”) by and between AVALON GLOBOCARE CORP., a Delaware corporation (the “Company”),
and LUISA INGARGIOLA (the “Executive”).

 

Recitals:

WHEREAS, the Executive
is a key employee of the Company who possesses valuable proprietary knowledge of the Company, its business and operations and the
markets in which the Company competes; and

 

WHEREAS, the Company
and the Executive desire to enter into this Agreement to encourage the Executive to continue to devote the Executive’s full
attention, except to the extent that Executive serves as a member of the Board of Directors for other companies, and dedication
to the success of the Company, and to provide specified compensation and benefits to the Executive in the event of a Termination
Upon Change of Control or certain other terminations pursuant to the terms of this Agreement.

 

NOW, THEREFORE, THE PARTIES HEREBY AGREE
AS FOLLOWS:

 

1.            PURPOSE
AND TERM; DUTIES

 

1.1           The
purpose of this Agreement is to provide specified compensation and benefits to the Executive in the event of (i) a Termination
Upon Change of Control or (ii) an Involuntary Termination. Subject to the terms of any applicable written employment agreement
between Company and the Executive (as to which Executive acknowledges no other such agreement exists as of the date hereof), either
the Executive or Company may terminate the Executive’s employment at any time for any reason, with or without notice. The
term of this Agreement shall be the period from the date set forth above until Executive’s employment is terminated for any
reason or this Agreement is terminated by mutual agreement of the parties.

 

1.2           The
Executive’s job responsibilities will comprise managing and overseeing all financial operations and matters of the Company,
including the subsidiaries, including but not limited to:

 

		(a)	Timely and accurate annual and quarterly financial reporting
in accordance with Securities & Exchange Commission (“SEC”) rules and regulations, applicable law and United States
Generally Accepted Accounting Principles (“GAAP”).

 

		(b)	Management of our Finance Department and oversight of all financial personnel, accounting systems,
procedures and policies.

 

		(c)	Establishing and maintaining adequate financial controls, sufficient as a minimum to enable your
appropriate certification of the Company’s annual and quarterly reports in accordance with SEC rules.

 

    	 	-1-	 

     

    

 

		(d)	Managing the treasury functions for the Company, as well
as all borrowings, debt facilities and equity fundraising, subject to the approval of the Board of Directors of the Company (the
“Board”).

 

		(e)	Undertaking financial planning for the Company, including preparing annual and other budgets and
projections and managing in compliance with such budgets as may be approved by the Board.

 

		(f)	Monthly management reporting and analysis for the Board.

 

		(g)	Investor relations to the extent reasonably requested by
the CEO.

 

		(h)	All such functions as are customarily applicable to your
position, as well as those that are reasonably assigned to you by the Company.

 

1.3           The
Executive will initially work from Florida. As part of Executive’s duties Executive will
be required to travel to the Company’s offices in New Jersey. The Executive is entitled to four (4) weeks of vacation
which will accrue on a pro-rata basis during the year, in addition to all public holidays when the office is closed.   Executive
will be eligible to participate in all employee benefit plans established by the Company for its employees from time to time. In
accordance with Company policies from time to time, Executive will reimburse you for all reasonable and proper travel and business
expenses incurred by you in the performance of your duties.

 

2.          COMPENSATION
AND TERMINATION GENERALLY

 

2.1           Compensation.

 

2.1.1           Annual
Salary. The Executive’s current base salary of $200,000 per annum, which shall be increased to $225,000 on the 60 day
anniversary of the Effective Date, shall remain in place, but shall be subject to periodic review and modification by the Company’s
Board of Directors (the “Board”) as may be delegated to the Compensation Committee of the Board (references
herein to the Compensation Committee shall include reference to the Board if no such Committee exists at any time) at such time
or times as it shall determine. The Company’s Compensation Committee shall also from time to time, in its discretion, determine
the type and amount of other forms of compensation for Executive’s service with the Company (including, without limitation,
stock options or other forms of equity awards).

 

2.1.2           Bonuses.
Executive will be eligible for bonuses based on achievement of performance milestones, calculated
and payable as follows:

 

		(a)	An amount equal to 50% of the base salary (as amended by
the Board from time to time), which shall be payable in the event that (1) the Company’s Annual Report on Form 10K for the
year 2017 is filed on a timely basis, all Quarterly Reports on Form 10Q having previously been filed; AND (2) the Company has
raised not less than $20,000,000 in gross proceeds in investment funding (whether debt or equity) after the date hereof. In the
event all requirements of this section have been satisfied exempt that the requirement under Section 2.1.2(a)(1) has not been
satisfied due to an Internal Control Event (as defined below), then the Executive shall be entitled to the bonus under this Section,

 

    	 	-2-	 

     

    

 

If
such conditions are fulfilled, the above bonus shall be payable with the next payroll following the latest to occur of the above
events, subject to all applicable deductions required by law; and

 

		(b)	An amount equal to 100% of the base salary, which
shall be payable upon the first to occur of any of the following events (1) the occurrence of a Change of Control, (as defined
below); OR (2) the filing of Company’s Annual Report on Form 10K in any year, which Report shows that the Company has achieved
Adjusted EBITDA for the year, as reported therein, which is not less $10,000,000; OR (3) the Company’s shares becoming listed
on a national securities exchange AND if the Board determines that additional equity funding is required, the Company’s
closing (whether at the time of listing or subsequent thereto) of a public offering of its equity, raising not less than $10,000,000
in gross proceeds in the aggregate. If such conditions are fulfilled, or waived by the Board, the above bonus shall be payable
with the next payroll following the occurrence of the relevant event, subject to all applicable deductions required by law.

 

 

2.1.3           Options.
The Executive will be provided with an initial grant of options to purchase 2,000,000 shares of common
stock, vesting over three (3) years, one third on the first anniversary of the Effective Date and the balance in equal quarterly
installments.  The exercise price of the options shall be $0.50 per share and the term shall be five years. The Executive
may be eligible for additional equity incentive grants, subject to Executive’s continued employment and satisfactory job
performance, which may be made from time to time, by the Board, on the same terms as other executive employees of the Company. Terms
and conditions of all the equity incentive grants, will be in accordance with the terms of the Company’s Equity Incentive
Plan in effect at the time of each such grant.

 

2.2           Termination
of Employment Generally. In the event the Executive’s employment with the Company terminates, for any reason whatsoever
including death or disability the Executive shall be entitled to the benefits described in this Section 2.2.

 

2.2.1           Accrued
Salary and Vacation. All salary and accrued vacation earned through the Termination Date shall be paid to Executive on such
date.

 

2.2.2           Accrued
Bonus Payment. The Executive shall receive a lump sum payment of any actual bonus amount to the extent that all the conditions
for payment of such bonus have been satisfied and any such bonus was earned and is unpaid on the Termination Date.

 

2.2.3           Expense
Reimbursement. Within ten (10) days following submission to the Company of proper expense reports by the Executive, the Company
shall reimburse the Executive for all expenses incurred by the Executive, consistent with the Company’s expense reimbursement
policy in effect prior to the incurring of each such expense, in connection with the business of the Company prior to the Termination
Date.

 

    	 	-3-	 

     

    

 

2.2.4           Equity
Compensation. The period during which the Executive may exercise any rights (“Exercise Period”) under
any outstanding stock options and shares of restricted stock (or any other equity award, including, without limitation, stock appreciation
rights and restricted stock units) granted to the Executive under any equity incentive plan or agreement (the “Company
Plans”) shall be extended governed under the terms of such equity incentive plan or agreement.

 

3.          TERMINATION
UPON CHANGE OF CONTROL

 

3.1           Severance
Payment. In the event of the Executive’s Termination Upon Change of Control, the Executive shall be entitled to receive
an amount equal to the amount set forth in Section 4.1 which shall be paid according to the following schedule: (i) a lump sum
payment equal to one-half of such amount shall be payable within ten (10) days following the Termination Date, and (ii) one-third
of the balance of such amount shall be payable within ten (10) days of each of the three-month, six-month and nine-month anniversaries
of the Termination Date (and in each case no interest shall accrue on such amount); provided, however, that if Section 409A of
the Code would otherwise apply to such cash severance payment, it instead shall be paid at such time as permitted by Section 409A
of the Code. In addition to the foregoing severance payment, in the event of the Executive’s Termination Upon Change of Control,
the Executive shall be entitled to receive, within ten (10) days following the Termination Upon Change of Control, a lump sum payment
equal to one hundred percent (100%) of (a) any actual bonus amount earned with respect to a previous year to the extent that all
the conditions for payment of such bonus have been satisfied (excluding any requirement to be in employment with the Company as
of a given date which is after the Termination Date) and any such bonus was earned but is unpaid on the Termination Date; and (b)
the target bonus then in effect for the Executive for the year in which such termination occurs, such payment to be prorated to
reflect the full number of months the Executive remained in the employ of the Company; provided, however, that if Section 409A
of the Code would otherwise apply to such cash payment, it instead shall be paid at such time as permitted by Section 409A of the
Code. To illustrate, if the Executive’s target bonus at 100% equals $120,000 for the calendar year and the Executive is terminated
on October 15th, then the foregoing payment shall equal $100,000 (i.e., ten (10) months’ prorated bonus at one
hundred percent (100%) with October counting as a full month worked).

 

3.2           Equity
Compensation Acceleration. Upon the Executive’s Termination Upon Change of Control, the vesting and exercisability of
all then outstanding stock options and shares of restricted stock (or any other equity award, including, without limitation, stock
appreciation rights and restricted stock units) granted to the Executive under any Company Plans shall be accelerated
as to 100% of the shares subject to any such equity awards granted to the Executive. In addition, the Exercise Period, under the
Company Plans for the purposes of the Executive’s stock options granted under the Company Plans shall be extended so as to
expire on the last day of the term applicable to such stock option, as measured from the date of Termination Upon Change of Control.

 

3.3           COBRA.
If the Executive timely elects coverage under the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”),
the Company shall continue to provide to the Executive, at the Company’s expense, the Company’s health-related employee
insurance coverage for the employee only as in effect immediately prior to the Executive’s Termination Upon Change of Control
for a period of twelve (12) months following such Termination Upon Change of Control. The date of the “qualifying event”
for the Executive and any dependents shall be the Termination Date.

 

    	 	-4-	 

     

    

 

3.4           Indemnification.
In the event of the Executive’s Termination Upon Change of Control, (a) the Company shall continue to indemnify the Executive
against all claims related to actions arising prior to the termination of the Executive’s employment to the fullest extent
permitted by law, and (b) if the Executive was covered by the Company’s directors’ and officers’ insurance policy,
or an equivalent thereto, (the “D&O Insurance Policy”) immediately prior to the Change of Control,
the Company or its Successor shall continue to provide coverage under a D&O Insurance Policy for not less than twenty-four
(24) months following the Executive’s Termination Upon Change of Control on substantially the same terms of the D&O Insurance
Policy in effect immediately prior to the Change of Control.

 

4.          INVOLUNTARY
TERMINATION

 

4.1           Severance
Payment. In the event of the Executive’s Involuntary Termination, at any time after the expiration of six months from
the Effective Date the Executive shall be entitled to receive an amount equal to six (6) months of the Executive’s Base Salary
which shall be increased to twelve (12) months of the Executive’s Base Salary after the expiration of twelve months from
the Effective Date which shall be paid according to the following schedule: (i) a lump sum payment equal to one-fourth of such
amount shall be payable within ten (10) days following the Termination Date, and (ii) one-fourth of such amount shall be payable
within ten (10) days of each of the three-month, six-month and nine-month anniversaries of the Termination Date (and in each case
no interest shall accrue on such amount); provided, however, that if Section 409A of the Code would otherwise apply to such cash
severance payment, it instead shall be paid at such time as permitted by Section 409A of the Code. In addition to the foregoing
severance payment, in the event of the Executive’s Involuntary Termination, the Executive shall be entitled to receive, within
ten (10) days following the Executive’s Involuntary Termination, a lump sum payment equal to one hundred percent (100%) of
(a) any actual bonus amount earned with respect to a previous year to the extent that all the conditions for payment of such bonus
have been satisfied (excluding any requirement to be in employment with the Company as of a given date which is after the Termination
Date) and any such bonus was earned but is unpaid on the Termination Date; and (b) the target bonus then in effect for the Executive
for the year in which such termination occurs, such payment to be prorated to reflect the full number of months the Executive remained
in the employ of the Company; provided, however, that if Section 409A of the Code would otherwise apply to such cash payment, it
instead shall be paid at such time as permitted by Section 409A of the Code. To illustrate, if the Executive’s target bonus
at 100% equals $120,000 for the calendar year and the Executive is terminated on October 15th, then the foregoing payment
shall equal $100,000 (i.e., ten (10) months’ prorated bonus at one hundred percent (100%) with October counting as a full
month worked).

 

4.2           Equity
Compensation Acceleration. Upon the Executive’s Involuntary Termination, at any time after the expiration of twelve months
from the Effective Date, the vesting and exercisability of all then outstanding stock options (or any other equity award, including,
without limitation, stock appreciation rights and restricted stock units) granted to the Executive under any Company Plans shall
be accelerated as to 100% of the shares subject to any such equity awards granted to the Executive. In addition, the Exercise Period,
under the Company Plans for the purposes of the Executive’s stock options granted under the Company Plans shall be extended
so as to expire on the last day of the term applicable to such stock option, as measured from the date of Involuntary Termination.

 

4.3           COBRA.
In the event of the Executive’s Involuntary Termination, at any time after the expiration of twelve months after the Effective
Date, if the Executive timely elects coverage under the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”),
the Company shall continue to provide to the Executive, at the Company’s expense, the Company’s health-related employee
insurance coverage for the employee only as in effect immediately prior to the Executive’s Involuntary Termination for a
period of twelve (12) months following such Involuntary Termination. The date of the “qualifying event” for the Executive
and any dependents shall be the Termination Date.

 

    	 	-5-	 

     

    

 

4.4           Indemnification.
In the event of the Executive’s Involuntary Termination, (a) the Company shall continue to indemnify the Executive against
all claims related to actions arising prior to the Termination Date to the fullest extent permitted by law, and (b) if the Executive
was covered by the D&O Insurance Policy immediately prior to the Termination Date, the Company shall continue to provide coverage
under a D&O Insurance Policy for not less than twenty-four (24) months following the Executive’s Involuntary Termination
on substantially the same terms of the D&O Insurance Policy in effect immediately prior to the Termination Date.

 

5.          FEDERAL
EXCISE TAX UNDER SECTION 280G

 

5.1           Excise
Tax. If (a) any amounts payable to the Executive under this Agreement or otherwise are characterized as excess parachute payments
pursuant to Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), and (b) the Executive
thereby would be subject to any United States federal excise tax due to that characterization, then if Executive would thereby
be in a better after-tax position, the Company may elect, in the Company’s sole discretion, to reduce the amounts payable
under this Agreement or otherwise, or to have any portion of applicable options or restricted stock not vest or become exercisable,
in order to avoid any “excess parachute payment” under Section 280G(b)(1) of the Code.

 

5.2           Calculation
by Independent Public Accountants. Unless the Company and the Executive otherwise agree in writing, any calculation of
the amount of any excess parachute payments payable by the Executive shall be made in writing by the Company’s independent
public accountants (the “Accountants”) whose conclusion shall be final and binding on the parties. For
purposes of making such calculations, the Accountants may rely on reasonable, good faith interpretations concerning the application
of Sections 280G and 4999 of the Code. The Company and the Executive shall furnish to the Accountants such information and documents
as the Accountants may reasonably request in order to make the required calculations. The Company shall bear all fees and expenses
the Accountants may charge in connection with these services, but the engagement of the Accountants for this purpose shall be pursuant
to an agreement between the Executive and the Accountants.

 

6.          DEFINITIONS

 

6.1           Capitalized
Terms Defined. Capitalized terms used in this Agreement shall have the meanings set forth in this Section 4, unless the context
clearly requires a different meaning.

 

6.2           “Base
Salary” means the greater of (a) if applicable, the monthly salary of the Executive in effect immediately prior to the
Change of Control, or (b) the monthly salary of the Executive in effect immediately prior to the Termination Date.

 

6.3           “Cause”
means:

 

		(a)	the Executive willfully failed
to follow the lawful written directions of the Board of Directors of the Company or Executive’s immediate superior; provided
that no termination for such Cause shall occur unless the Executive: (i) has been provided with notice, specifying such willful
failure in reasonable detail, of the Company’s intention to terminate the Executive for Cause; and (ii) has failed to cure
or correct such willful failure within thirty (30) days of receiving such notice;

 

    	 	-6-	 

     

    

 

		(b)	the Executive engaged in
gross misconduct, or gross incompetence which is materially detrimental to the Company; provided that no termination for such
Cause shall occur unless the Executive: (i) has been provided with notice, specifying such gross misconduct or gross incompetence
in reasonable detail, of the Company’s intention to terminate the Executive for Cause; and (ii) has failed to cure or correct
such gross misconduct within thirty (30) days of receiving such notice;

 

		(c)	the Executive willfully failed
to comply in any material respect with the Employee Invention Assignment & Confidentiality Agreement, the Company’s
share dealing code, the Employee’s non-competition agreement or any other reasonable policies of the Company where non-compliance
would be materially detrimental to the Company; provided that no termination for such Cause shall occur unless the Executive:
(i) has been provided with notice of the Company’s intention to terminate the Executive for such Cause, and (ii) has failed
to cure or correct such willful failure within thirty (30) days of receiving such notice, provided that such notice and cure period
requirements shall not apply in the event that such non-compliance is of a nature that it is unable to be remedied; or

 

		(d)	is convicted of a felony
or crime involving moral turpitude (excluding drunk driving unless combined with other aggravating circumstances or offenses)
or commission of a fraud which the Company reasonably believes would reflect adversely on the Company.

 

6.4           “Change
of Control” means:

 

(a)          any
“person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”)) becomes the “beneficial owner” (as defined in Rule 13d-3 promulgated under
the Exchange Act), directly or indirectly, of securities of the Company representing fifty (50%) percent or more of (i) the outstanding
shares of common stock of the Company, or (ii) the combined voting power of the Company’s outstanding securities;

 

(b)          the
Company is party to a merger or consolidation, or series of related transactions, which results in the voting securities of the
Company outstanding immediately prior thereto failing to continue to represent (either by remaining outstanding or by being converted
into voting securities of the surviving entity), directly or indirectly, at least fifty (50%) percent of the combined voting power
of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation;

 

    	 	-7-	 

     

    

 

(c)          the
sale or disposition of all or substantially all of the Company’s assets, or consummation of any transaction, or series of
related transactions, having similar effect (other than to a subsidiary of the Company); 

 

6.5           
“Company” shall mean Avalon GloboCare Corp. and, following a Change of Control, any Successor.

 

6.6           “Involuntary
Termination” means:

 

(a)          any
termination without Cause of the employment of the Executive by the Company; or

 

(b)          any
resignation by Executive for Good Reason where such resignation occurs within one hundred twenty (120) days following the occurrence
of such Good Reason.

 

Notwithstanding the foregoing, the term
“Involuntary Termination” shall not include any termination of the employment of the Executive: (1) by the Company
for Cause; (2) by the Company as a result of the Permanent Disability of the Executive; (3) as a result of the death of the
Executive; (4) that occurs within the period of time to qualify as a “Termination Upon Change of Control”; or (5) as
a result of the voluntary termination of employment by the Executive for any reason other than Good Reason.

 

6.7           
“Good Reason” means the occurrence of any of the following conditions, without the Executive’s written
consent:

 

(a)          Any
act, set of facts or omissions with respect to the Executive that would, as a matter of applicable law, constitute a constructive
termination of the Executive.

 

(b)          The
assignment to the Executive of a title, position, responsibilities or duties that is not a “Substantive Functional Equivalent”
to the title, position, responsibilities or duties which the Executive had immediately prior to such assignment (including, as
relevant, immediately prior to the public announcement of the Change of Control).

 

(c)          A
reduction in the Executive’s Base Salary or, if applicable, target bonus opportunity (subject to applicable performance requirements
with respect to the actual amount of bonus compensation earned similar to the applicable performance requirements currently in
effect), and in the event of a Change of Control, as compared to Executive’s Base Salary and target bonus opportunity in
effect immediately prior to the public announcement of the Change of Control; provided, however, that this clause (c) shall not
apply in the event of a reduction in the Executive’s Base Salary or, if applicable, target bonus opportunity as part of a
Company-wide or executive team-wide cost-cutting measure or Company-wide or executive team-wide cutback as a result of overall
Company performance. 

 

    	 	-8-	 

     

    

 

(d)          The
failure of the Company (i) to continue to provide the Executive an opportunity to participate in any benefit or compensation plans
provided to employees who hold positions with the Company comparable to the Executive’s position, (ii) to provide the Executive
all other fringe benefits (or the equivalent) in effect for the benefit of any employee group which includes any employee who hold
a position with the Company comparable to the Executive’s position, where in the event of a Change of Control, such comparison
shall be made relative to the time immediately prior to the public announcement of such Change of Control); or (iii) continue to
provide director’s and officers’ insurance.

 

(e)          A
material breach of this Agreement by the Company, including, in the event of a Change of Control, failure of the Company to obtain
the consent of a Successor to perform all of the obligations of the Company under this Agreement.

 

(f)          Company's
lack of providing full and transparent access to all material financial. operational and transactional activities ‎of its executives,
board of directors, subsidiaries or joint ventures as it relates to the Company, which such failure continues for a period of a
minimum of 60 days following Executive’s written request to receive information or documentation pertaining to the aforementioned
items (“Internal Control Event”).

 

The Executive must first give the Company
an opportunity to cure any of the foregoing within thirty (30) days following delivery to the Company of a written explanation
specifying the specific basis for Executive’s belief that Executive is entitled to terminate employment for Good Reason,
and Executive terminates employment with the Company not later than (30) days following the Company’s failure to cure.

 

6.8           
“Permanent Disability” means that:

 

(a)          the
Executive has been incapacitated by bodily injury, illness or disease so as to be prevented thereby from engaging in the performance
of the Executive’s duties;

 

(b)          such
total incapacity shall have continued for a period of six consecutive months; and

 

(c)          such
incapacity will, in the opinion of a qualified physician, be permanent and continuous during the remainder of the Executive’s
life.

 

6.9           “Substantive
Functional Equivalent” means that the Executive’s position must:

 

(a)          be
in a substantive area of the Executive’s competence (e.g., finance or executive management) and not materially different
from the position occupied immediately prior;

 

(b)          allow
the Executive to serve in a role and perform duties functionally equivalent to those performed immediately prior; and

 

    	 	-9-	 

     

    

 

(c)          not
otherwise constitute a material, adverse change in authority, title, status, responsibilities or duties from those of the Executive
immediately prior, causing the Executive to be of materially lesser rank or responsibility, including requiring the Executive to
report to a person other than the Board.

 

6.10         “Successor”
means any successor in interest to, or assignee of, substantially all of the business and assets of the Company.

 

6.11         “Termination
Date” means the date of the termination of the Executive’s employment with the Company.

 

6.12         “Termination
Upon Change of Control” means:

 

(a)          any
termination of the employment of the Executive by the Company without Cause during the period commencing on or after the date that
the Company first publicly announces a definitive agreement that results in a Change of Control (even though still subject to approval
by the Company’s stockholders and other conditions and contingencies, but provided that the Change of Control actually occurs)
and ending on the date which is twelve (12) months following the Change of Control; or

 

(b)          any
resignation by Executive for Good Reason where (i) such Good Reason occurs during the period commencing on or after the date that
the Company first publicly announces a definitive agreement that results in a Change of Control (even though still subject to approval
by the Company’s stockholders and other conditions and contingencies, but provided that the Change of Control actually occurs)
and ending on the date which is twelve (12) months following the Change of Control, and (ii) such resignation occurs at or after
such Change of Control and in any event within six (6) months following the occurrence of such Good Reason.

 

Notwithstanding the foregoing, the term
“Termination Upon Change of Control” shall not include any termination of the employment of the Executive: (1) by the
Company for Cause; (2) by the Company as a result of the Permanent Disability of the Executive; (3) as a result of the death
of the Executive; or (4) as a result of the voluntary termination of employment by the Executive for any reason other than Good
Reason.

 

7.          EXCLUSIVE
REMEDY

 

7.1           No
Other Benefits Payable. The Executive shall be entitled to no other termination, severance or change of control compensation,
benefits, or other payments from the Company as a result of any termination with respect to which the payments and benefits described
in Section 2 have been provided to the Executive, except as expressly set forth in this Agreement.

 

7.2           No
Limitation of Regular Benefit Plans. Except as may be provided elsewhere in this Agreement, this Agreement is not intended
to and shall not affect, limit or terminate any plans, programs or arrangements of the Company that are regularly made available
to a significant number of employees or officers of the Company, including, without limitation, the Company’s stock option
plans.

 

    	 	-10-	 

     

    

 

7.3           Release
of Claims. The payment of the benefits described in Sections 3 and 4 of this Agreement is conditioned upon the delivery by
the Executive to the Company of a signed and effective general release of claims as provided by the Company; provided, however,
that the Executive shall not be required to release any rights the Executive may have to be indemnified by the Company or as otherwise
provided under this Agreement.

 

7.4           Noncumulation
of Benefits. The Executive may not cumulate cash severance payments, stock option vesting and exercisability and restricted
stock vesting under this Agreement, any other written agreement with the Company and/or another plan or policy of the Company.
If the Executive has any other binding written agreement with the Company which provides that, upon a Change of Control or Termination
Upon a Change of Control or Involuntary Termination, the Executive shall receive termination, severance or similar benefits, then
no benefits shall be received by Executive under this Agreement unless, prior to payment or receipt of benefits under this Agreement,
the Executive waives Executive’s rights to all such other benefits, in which case this Agreement shall supersede any such
written agreement with respect to such other benefits.

 

8.          NON-COMPETE;
PROPRIETARY AND CONFIDENTIAL INFORMATION

 

During the term of this Agreement and following
any termination of employment, Executive agrees to continue to abide by the terms and conditions of each of the non-competition
agreement (during the term of such Agreement) and the Employee Invention Assignment & Confidentiality Agreement between the
Executive and the Company.

 

9.          ARBITRATION

 

9.1           Disputes
Subject to Arbitration. Any claim, dispute or controversy arising out of this Agreement (other than claims relating to misuse
or misappropriation of the intellectual property of the Company), the interpretation, validity or enforceability of this Agreement
or the alleged breach thereof shall be submitted by the parties to binding arbitration by a sole arbitrator under the rules of
the American Arbitration Association; provided, however, that (a) the arbitrator shall have no authority to make any ruling or
judgment that would confer any rights with respect to the trade secrets, confidential and proprietary information or other intellectual
property of the Company upon the Executive or any third party; and (b) this arbitration provision shall not preclude the Company
from seeking legal and equitable relief from any court having jurisdiction with respect to any disputes or claims relating to or
arising out of the misuse or misappropriation of the Company’s intellectual property. Judgment may be entered on the award
of the arbitrator in any court having jurisdiction.

 

9.2           Costs
of Arbitration. All costs of arbitration, including reasonable attorney’s fees of the Executive, will be borne by the
Company, except that if the Executive initiates arbitration and the arbitrator finds the Executive’s claims to be frivolous
the Executive shall be responsible for his own costs and attorneys fees.

 

9.3           Site
of Arbitration. The site of the arbitration proceeding shall be in New York City, New York.

 

    	 	-11-	 

     

    

 

10.         NOTICES

 

For purposes of this Agreement, notices
and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when
delivered or five (5) business days after being mailed, return receipt requested, as follows: (a) if to the Company, attention:
Chief Executive Officer, at the Company’s offices at 83 South Street, Suite 101, Freehold, New Jersey 07728 and, (b) if to
the Executive, at the address indicated below or such other address specified by the Executive in writing to the Company. Either
party may provide the other with notices of change of address, which shall be effective upon receipt.

 

11.         MISCELLANEOUS
PROVISIONS

 

11.1         Heirs
and Representatives of the Executive; Successors and Assigns of the Company. This Agreement shall be binding upon and shall
inure to the benefit of and be enforceable by the Executive’s personal and legal representatives, executors, administrators,
successors, heirs, distributees, devises and legatees. This Agreement shall be binding upon and inure to the benefit of and be
enforceable by the successors and assigns of the Company.

 

11.2         Amendment
and Waiver. No provision of this Agreement shall be modified, amended, waived or discharged unless the modification, amendment,
waiver or discharge is agreed to in writing, specifying such modification, amendment, waiver or discharge, and signed by the Executive
and by an authorized officer of the Company (other than the Executive). No waiver by either party of any breach of, or of compliance
with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision
or of the same condition or provision at another time.

 

11.3         Withholding
Taxes. All payments made under this Agreement shall be subject to deduction of all federal, state, local and other taxes required
to be withheld by applicable law.

 

11.4         Severability.
The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability
of any other provision hereof, which shall remain in full force and effect.

 

11.5         Choice
of Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State
of New Jersey, without regard to where the Executive has his residence or principal office or where he performs his duties hereunder.

 

11.6         No
Duty to Mitigate. The Executive is not required to seek alternative employment following termination, and payments called for
under this Agreement will not be reduced by earnings from any other source.

 

11.7.          Section
409A of the Code. To the extent (a) any payments or benefits to which Employee becomes entitled under this Agreement, or under
any agreement or plan referenced herein, in connection with Employee’s termination of employment with the Company constitute
deferred compensation subject to Section 409A of the Code and (b) Employee is deemed at the time of such termination of employment
to be a “specified employee” under Section 409A of the Code, then such payments shall not be made or commence until
the earliest of (i) the expiration of the six (6)-month period measured from the date of Employee’s “separation from
service” (as such term is at the time defined in Treasury Regulations under Section 409A of the Code) from the Company; or
(ii) the date of Employee’s death following such separation from service; provided, however, that such deferral shall only
be effected to the extent required to avoid adverse tax treatment to Employee, including (without limitation) the additional twenty
percent (20%) tax for which Employee would otherwise be liable under Section 409A(a)(1)(B) of the Code in the absence of such deferral.
Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether
in a single sum or in installments) in the absence of this paragraph shall be paid to Employee or Employee’s beneficiary
in one lump sum (without interest). Any termination of Employee’s employment is intended to constitute a “separation
from service” as such term is defined in Treasury Regulation Section 1.409A-1. It is intended that each installment of the
payments provided hereunder constitute separate “payments” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i).
It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemption from the application of
Code Section 409A (and any state law of similar effect) provided under Treasury Regulation Section 1.409A-1(b)(4) (as a “short-term
deferral”).

 

    	 	-12-	 

     

    

 

11.8         Entire
Agreement. This Agreement represents the entire agreement and understanding between the parties as to the subject matter herein
(whether oral or written and whether express or implied).

 

[SIGNATURE PAGE TO EXECUTIVE RETENTION
AGREEMENT FOLLOWS]

 

    	 	-13-	 

     

    

 

In
Witness Whereof, each of the parties has executed this Agreement, in the case of the Company, by its duly authorized officer,
as of the day and year first above written.

 

	 	Executive
	 	 
	 	/s/ Luisa Ingargiola
	 	 
	 	Luisa Ingargiola
	 	 
	 	Avalon GloboCare Corp.
	 	 
	 	By: 	/s/ David Jin
	 	 	David Jin, CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]